The answer is the ideal amount of B12 varies depending on factors like age
14 A calculator to assess cardiovascular disease risk in people with type 2 diabetes is available here: Clinical scenarios where empagliflozin or dulaglutide are recommended, but not funded The recently released type 2 diabetes management guidelines developed by the New Zealand Society for the Study of Diabetes (NZSSD), and supported by the Ministry of Health, state that while the Special Authority criteria for empagliflozin and GLP-1 receptor agonists ensure access for those at high risk of cardiovascular and renal disease, the funding restriction is not fully consistent with best practice
J.WainwrightC.et al (2012)
Dosing protocols when combining both medications Getting the dosing right for both medications simultaneously requires understanding each one's titration schedule and how they overlap in practice
This medication is taken once daily on an empty stomach, at least 30 minutes before the first food, beverage, or other oral medication of the day
What safety measures should be followed when using GLP-1 medications for advanced kidney disease
